179 related articles for article (PubMed ID: 15208491)
1. The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective.
Lucignani G; Paganelli G; Bombardieri E
Nucl Med Commun; 2004 Jul; 25(7):651-6. PubMed ID: 15208491
[TBL] [Abstract][Full Text] [Related]
2. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients.
Dimitrakopoulou-Strauss A; Strauss L
Hell J Nucl Med; 2006; 9(1):10-21. PubMed ID: 16617388
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
[TBL] [Abstract][Full Text] [Related]
4. Quantification in clinical fluorodeoxyglucose positron emission tomography.
Hallett WA
Nucl Med Commun; 2004 Jul; 25(7):647-50. PubMed ID: 15208490
[TBL] [Abstract][Full Text] [Related]
5. Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values.
Jaskowiak CJ; Bianco JA; Perlman SB; Fine JP
J Nucl Med; 2005 Mar; 46(3):424-8. PubMed ID: 15750154
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of the factors affecting accuracy of SUV measurements.
Adams MC; Turkington TG; Wilson JM; Wong TZ
AJR Am J Roentgenol; 2010 Aug; 195(2):310-20. PubMed ID: 20651185
[TBL] [Abstract][Full Text] [Related]
7. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer?
Basu S; Alavi A
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1527-9. PubMed ID: 17522857
[No Abstract] [Full Text] [Related]
8. Test-Retest Variability in Lesion SUV and Lesion SUR in
Hofheinz F; Apostolova I; Oehme L; Kotzerke J; van den Hoff J
J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598
[TBL] [Abstract][Full Text] [Related]
9. Standards for PET image acquisition and quantitative data analysis.
Boellaard R
J Nucl Med; 2009 May; 50 Suppl 1():11S-20S. PubMed ID: 19380405
[TBL] [Abstract][Full Text] [Related]
10. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.
Westerterp M; Pruim J; Oyen W; Hoekstra O; Paans A; Visser E; van Lanschot J; Sloof G; Boellaard R
Eur J Nucl Med Mol Imaging; 2007 Mar; 34(3):392-404. PubMed ID: 17033848
[TBL] [Abstract][Full Text] [Related]
11. Standardization and quantification in FDG-PET/CT imaging for staging and restaging of malignant disease.
Gámez-Cenzano C; Pino-Sorroche F
PET Clin; 2014 Apr; 9(2):117-27. PubMed ID: 25030277
[TBL] [Abstract][Full Text] [Related]
12. Shortened dynamic (18)F-FDG PET.
Disselhorst JA; Vriens D; de Geus-Oei LF; Oyen WJ; Visser EP
J Nucl Med; 2011 Aug; 52(8):1330; author reply 1330-1. PubMed ID: 21764799
[No Abstract] [Full Text] [Related]
13. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET.
Akamatsu G; Mitsumoto K; Taniguchi T; Tsutsui Y; Baba S; Sasaki M
Eur J Radiol; 2014 Jan; 83(1):226-30. PubMed ID: 24144448
[TBL] [Abstract][Full Text] [Related]
14. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.
Stahl A; Ott K; Schwaiger M; Weber WA
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1471-8. PubMed ID: 15257418
[TBL] [Abstract][Full Text] [Related]
16. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.
Conrad GR; Sinha P
Nucl Med Commun; 2003 Nov; 24(11):1129-37. PubMed ID: 14569166
[TBL] [Abstract][Full Text] [Related]
17. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
[TBL] [Abstract][Full Text] [Related]
18. Reliability of semiquantitative ¹⁸F-FDG PET parameters derived from simultaneous brain PET/MRI: a feasibility study.
Jena A; Taneja S; Goel R; Renjen P; Negi P
Eur J Radiol; 2014 Jul; 83(7):1269-1274. PubMed ID: 24813529
[TBL] [Abstract][Full Text] [Related]
19. Glucose-normalized standardized uptake value from (18)F-FDG PET in classifying lymphomas.
Wong CY; Thie J; Parling-Lynch KJ; Zakalik D; Margolis JH; Gaskill M; Hill J; Qing F; Fink-Bennett D; Nagle C
J Nucl Med; 2005 Oct; 46(10):1659-63. PubMed ID: 16204716
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]